Windtree Therapeutics Inc (WINT) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The companys lead development product Aerosurf (lucinactant for inhalation), is an investigational combination drug/device product for the treatment of respiratory distress syndrome (RDS) in premature infants. Its technology platforms comprise a novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant, which is structurally similar to pulmonary surfactant, and proprietary drug delivery technologies for the delivery of aerosolized KL4 surfactant and other inhaled therapies. Windtree Therapeutics is headquartered in Warrington, Pennsylvania, the US.

Windtree Therapeutics Inc (WINT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Windtree Therapeutics Enters into Agreement with Eleison Pharma 11
Equity Offering 12
Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 12
Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units 14
Discovery Labs Raises USD40.2 Million in Public Offering of Units 16
Discovery Laboratories Completes Public Offering Of Shares For US$50 Million 18
Discovery Labs Completes Public Offering Of Shares For US$14.2 Million 19
Discovery Labs Announces Public Offering Of Shares For US$25 Million 20
Discovery Labs Completes Public Offering Of Common Stock For US$45 Million 21
Windtree Therapeutics Inc - Key Competitors 23
Windtree Therapeutics Inc - Key Employees 24
Windtree Therapeutics Inc - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Nov 14, 2017: Windtree Therapeutics Reports Third Quarter 2017 Financial Results 26
Aug 21, 2017: Windtree Therapeutics Reports Second Quarter 2017 Financial Results 28
May 15, 2017: Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates 30
Mar 31, 2017: Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates 32
Clinical Trials 34
Jan 04, 2018: Windtree Therapeutics to Provide AEROSURF and Business Updates 34
Jun 29, 2017: Windtree Announces Top-Line Results from AEROSURF Phase 2b Clinical Trial for the Treatment of Respiratory Distress Syndrome in Premature Infants 35
Apr 11, 2017: Windtree Announces Successful Completion of Second and Final AEROSURF Phase 2b Clinical Trial Interim Safety Review 37
Feb 16, 2017: Windtree Therapeutics Aerosolized KL4 Surfactant Reduces Lung Inflammation and Improves Survival in a High-Pathogen Avian Influenza Preclinical Study 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List Of Tables

List of Tables
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Windtree Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Windtree Therapeutics Enters into Agreement with Eleison Pharma 11
Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 12
Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units 14
Discovery Labs Raises USD40.2 Million in Public Offering of Units 16
Discovery Laboratories Completes Public Offering Of Shares For US$50 Million 18
Discovery Labs Completes Public Offering Of Shares For US$14.2 Million 19
Discovery Labs Announces Public Offering Of Shares For US$25 Million 20
Discovery Labs Completes Public Offering Of Common Stock For US$45 Million 21
Windtree Therapeutics Inc, Key Competitors 23
Windtree Therapeutics Inc, Key Employees 24
Windtree Therapeutics Inc, Other Locations 25
Windtree Therapeutics Inc, Subsidiaries 25

List Of Figures

List of Figures
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Windtree Therapeutics Inc (WINT) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and

USD 250 View Report

Windtree Therapeutics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Windtree Therapeutics Inc Company Profile is a detailed strategic and analytical report on Windtree Therapeutics Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

BioClin Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioClin Therapeutics Inc (BioClin) is a clinical stage biotechnology company developing protein therapeutics for genetic disorders. Its lead product candidate B-701 is a human monoclonal antibody which targets the activity

USD 250 View Report

Torque Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Torque Therapeutics Inc (Torque) is an immuno-oncology company focused on developing first-in-class deep primed T Cell therapeutics to cure cancer. Its product pipeline includes Deep IL-15 used for for hematologic

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available